Concepedia

Maintenance Therapy with 3-monthly Bacillus Calmette-Guérin for 3 Years is Not Superior to Standard Induction Therapy in High-risk Non–muscle-invasive Urothelial Bladder Carcinoma: Final Results of Randomised CUETO Study 98013

Luis Martínez‐Piñeiro, José Antonio Portillo, José A. Zabala, Iker Cadierno, J.L. Moyano, Eduardo Solsona, Miguel Unda, Pastora Beardo, Jesús Rodríguez-Molina, V. Chantada,

European Urology · 2015 · 80 citations · 11 references

DOIFull text

Open access

Concepts

References

11

EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016

Marko Babjuk, Andreas Böhle, Maximilian Burger et al. · European Urology · 2016 · 2.3K citations

, , +16

MAINTENANCE BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY FOR RECURRENT TA, T1 AND CARCINOMA IN SITU TRANSITIONAL CELL CARCINOMA OF THE BLADDER: A RANDOMIZED SOUTHWEST ONCOLOGY GROUP STUDY

Donald L. Lamm, Brent A. Blumenstein, John D. Crissman et al. · The Journal of Urology · 2000 · 1.3K citations

, , +11

World Medical Association Declaration of Helsinki

JAMA · 1997 · 1K citations

, , +2

Variability in the Recurrence Rate at First Follow-up Cystoscopy after TUR in Stage Ta T1 Transitional Cell Carcinoma of the Bladder: A Combined Analysis of Seven EORTC Studies

Maurizio Brausi, Laurence Collette, Karl‐Heinz Kurth et al. · European Urology · 2002 · 683 citations

, , +10

Predicting Nonmuscle Invasive Bladder Cancer Recurrence and Progression in Patients Treated With Bacillus Calmette-Guerin: The CUETO Scoring Model

J.M. Fernández Gómez, Rosário Madero, Eduardo Solsona et al. · The Journal of Urology · 2009 · 655 citations · Full text

, , +9